MusclePharm (MusclePharm) Retained Earnings : $-211.84 Mil (As of Mar. 2022)

View and export this data going back to 2008. Start your Free Trial

What is MusclePharm Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. MusclePharm's retained earnings for the quarter that ended in Mar. 2022 was $-211.84 Mil.

MusclePharm's quarterly retained earnings declined from Sep. 2021 ($-198.76 Mil) to Dec. 2021 ($-205.54 Mil) and declined from Dec. 2021 ($-205.54 Mil) to Mar. 2022 ($-211.84 Mil).

MusclePharm's annual retained earnings increased from Dec. 2019 ($-195.86 Mil) to Dec. 2020 ($-192.67 Mil) but then declined from Dec. 2020 ($-192.67 Mil) to Dec. 2021 ($-205.54 Mil).

MusclePharm Retained Earnings Historical Data

The historical data trend for MusclePharm's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MusclePharm Retained Earnings Chart

MusclePharm Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Retained Earnings

Get a 7-Day Free Trial

-161.97

-176.88

-195.86

-192.67

-205.54

MusclePharm Quarterly Data
	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22
Retained Earnings	Get a 7-Day Free Trial															-192.58	-194.83	-198.76	-205.54	-211.84

MusclePharm Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

MusclePharm (OTCPK:MSLPQ) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.

MusclePharm (MusclePharm) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » MusclePharm Corp (OTCPK:MSLPQ) » Definitions » Retained Earnings

Comparable Companies

Traded in Other Exchanges

N/A

Address

6728 W. Sunset Road, Suite 130, Las Vegas, NV, USA, 89118

Website

https://www.musclepharmcorp.com

MusclePharm Corporation is a performance lifestyle company. It develops, manufactures, markets and distributes branded nutritional supplements. It offers various types of powders, capsules, tablets and gels. Geographically, the firm has its business presence across the region of US and in the international market of which the US accounts for the majority of revenue. MusclePharm's Hybrid series products include Assault, Combat Protein Powder, BCAA 3:1:2, CLA Core, Fish Oil, Combat Crunch Protein Bars, glutamine, carnitine, Combat Crunch, Protein Crisp, Organic Protein, and Protein Cookie. The group sells its products to various fitness enthusiasts, such as professional, combat sport, weight training, bodybuilding, running, and various team and individual sports, and others.

Executives

Eric Chin	officer: Chief Accounting Officer	1668 S. GARFIELD AVE., 2ND FLOOR, ALHAMBRA CA 91801
Paul W Karr	director	BRISTOL MEYERS SQUIBB CO, 345 PARK AVENUE, NEW YORK NY 10154
Sabina Rizvi	officer: President & CFO	6728 W. SUNSET ROAD, SUITE 130, LAS VEGAS NV 89118
Michael David Heller	director	4500 PARK GRANADA, SUITE 202, CALABASAS CA 91302
Wynnefield Partners Small Cap Value Lp I	10 percent owner	450 SEVENTH AVENUE, SUITE 509, NEW YORK NY 10123
Donald Feagan	10 percent owner	2150 SOUTH 1300 EAST STREET, SUITE 500, SALT LAKE CITY UT 84106
Amerop Holdings, Inc.	10 percent owner	1800 BROADWAY, SUITE 100, BOULDER CO 80302
White Winston Select Asset Fund Series Fund Mp-18, Llc	10 percent owner	C/O WHITE WINSTON SELECT ASSET FUNDS, LLC, 265 FRANKLIN ST., SUITE 1702, BOSTON MA 02110
Robert P Mahoney	10 percent owner	4 DANIELS FARM ROAD, #305, TRUMBULL CT 06611
White Winston Select Asset Funds, Llc	10 percent owner	265 FRANKLIN STREET, SUITE 1702, BOSTON MA 02110
Todd M. Enright	10 percent owner	2150 SOUTH 1300 EAST STREET, SUITE 500, SALT LAKE CITY UT 84106
Mark Blundell	10 percent owner	8 MACDONALD AVE, ARMOUK NY 10504
John J Desmond	director	10 GLEN HEAD ROAD, GLEN HEAD NY 11545
Wynnefield Small Cap Value Offshore Fund Ltd	10 percent owner	450 SEVENTH AVE, STE 509, NEW YORK NY 10123
Wynnefield Capital Inc	10 percent owner	450 SEVENTH AVE, STE 509, NEW YORK NY 10123